Answer: Pfizer
Notes: Medicines Patent Pool (MPP) is a United Nations-backed public health organization working to increase access to life-saving medicines for low- and middle-income countries. Pfizer Inc. and MPP signed a voluntary license agreement for Pfizer’s COVID-19 oral antiviral treatment candidate ‘PF-07321332’. The agreement will enable MPP to facilitate additional production and distribution of the antiviral and to provide greater access to the global population.
